BioArctic Neruoscience AB
17Patents
17Active
17Granted
52Portfolio score
Filing activity: Mar 17, 2005 → Jul 20, 2016 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8106164B2 | Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof | Physics | 30 | Active |
| US8025878B2 | Protofibril selective antibodies and the use thereof | Physics | 30 | Active |
| US8632776B2 | Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies | Physics | 20 | Active |
| US8859501B2 | Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies | Physics | 13 | Active |
| US9084832B2 | Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies | Physics | 12 | Active |
| US7700719B2 | Arctic β amyloid protofibril | Human Necessities | 9 | Active |
| US8809506B2 | Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders | Emerging Cross-Sectional Technologies | 8 | Active |
| US8968734B2 | Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies | Physics | 8 | Active |
| US8409575B2 | Antibodies specific for amyloid beta protofibril | Human Necessities | 7 | Active |
| US9315569B2 | Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US9034334B2 | Protofibril selective antibodies and the use thereof | Physics | 3 | Active |
| US8404459B2 | Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof | Physics | 2 | Active |
| US9573994B2 | Aβ protofibril binding antibodies | Physics | 2 | Active |
| US8999936B2 | Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof | Physics | 1 | Active |
| US7709695B1 | Transgenic mouse expressing arctic mutation E693G | Human Necessities | 0 | Active |
| US11327080B2 | Method for treatment of traumatic brain injury targeting aggregated peptides | Physics | 0 | Active |
| US9895234B2 | Spinal cord devices and methods for promoting axonal regeneration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.